View More Recent Stories
-
KeyBanc Reiterates Overweight Rating on Repligen (RGEN)
-
Stifel on Repligen (RGEN) M&A Speculation with Maravai (MRVI)
-
Midday movers: H&R Block, Maravai LifeSciences rise; Applied Materials falls
-
Repligen (RGEN) Has Approached Maravai Lifesciences (MRVI) with an Acquisition Offer - Reuters
-
Repligen (RGEN) Reports In-Line Q2 EPS, provides guidance
-
Repligen (RGEN) to Acquire Chromatography Innovator Tantti
-
Repligen (RGEN) discoveres unauthorized third party had accessed certain files on the Company’s information systems
-
Deutsche Bank New Quarterly Feature Called 'Fresh Money List' Picks, 17 Additions
-
Deutsche Bank Upgrades Repligen (RGEN) to Buy
-
Stifel Out Positive on Repligen (RGEN): 'current levels seem as though they will have proven to be good ones'
-
Repligen (RGEN) Announces CEO Transition Plan

